Quantity
|
Out of stock
|
||
|
🐕 ACTIVIL TABS🐈 PROBIOTIC + IMMUNITY
1 tablet:
Clostridium butyricum, not less than 10x104 CFU
Bacillus licheniformis, not less than 10x105 CFU
Bacillus subtilis, not less than 10x105 CFU
To balance and improve the gastrointestinal microbiocenosis in cats and dogs after antibiotic therapy, in cases of impaired functional status of the gastrointestinal tract in animals.
The supplement is used as an adjuvant in the prevention and treatment of gastrointestinal infections of bacterial and viral aetiology, to normalise the intestinal microflora in cases of dysbiosis of various origins, to improve feed digestion, to increase natural immunity and immune levels during and after vaccination.
🟢 DOSAGE AND METHOD OF ADMINISTRATION:
For prophylactic purposes, the tablets are administered orally to the animals 2-3 times a day during the main feeding, either separately or mixed with the feed in crushed form or by force feeding on the root of the tongue in the following doses:
🔹 for large dogs - 2 tablets
🔹 for medium dogs - 1-2 tablets
🔹 cats and small dogs - ½-1 tablet
After completion of antibiotic therapy, the probiotic should be continued for at least 14 days.
If necessary and on the recommendation of your veterinarian, the dose and duration of use can be increased.
⚠️PRZECIWWSKAZANIA:
Do not use in combination with drugs with disinfectant properties.
SIDE EFFECTS:
Not stated
SPECIAL PRECAUTIONS FOR USE:
Do not use in animals allergic to dairy products and egg white.
USE DURING PREGNANCY AND LACTATION:
Not specified
⚠️INTERAKCJE WITH OTHER PRODUCTS AND OTHER FORMS OF INTERACTION:
The probiotic bacteria Bacillus subtilis and Bacillus licheniformis, which are included in the feed supplement, are insensitive to antibiotics such as colistin sulphate, gentamicin, amoxicillin, neomycin, streptomycin.
When the supplement is used in combination with Gram-positive spectrum antibiotics, a partial decrease in the effectiveness of the supplement can be observed.
Combination with coccidiostats is possible
PHARMACOLOGICAL PROPERTIES:
ACTIVIL TABS - belongs to the IV generation of probiotics and contains spores of live bacteria Bacillus licheniformis, Bacillus subtilis, Clostridium butyricum.
Aktivil TABS is resistant to external factors - the aggressive environment of the gastrointestinal tract and some antibiotics thanks to the use of spore-forming microorganisms.
Bacillus subtilis is a spore-forming bacterium that inhibits the growth of pathogenic bacteria by competitively displacing them without inducing resistance. It produces lysozyme and peptides with antibiotic properties in the gut, as well as a large number of enzymes that significantly improve digestive processes in animals.
Bacillus licheniformis is a spore-forming bacterium that synthesises vitamins in the digestive tract, such as vitamin K, riboflavin and folic acid. It helps to maintain the acid-base balance in the large intestine, produces lactic acid, which stimulates the growth of lactic acid bacilli and inhibits the growth of pathogenic micro-organisms, and aids in the absorption of nutrients.
Clostridium butyricum is a spore-forming bacterium that synthesises N-butyric acid, an energy source that accelerates enterocyte division and restores the integrity of the intestinal epithelium. N-butyric acid has antimicrobial activity against Gram-negative bacteria, in particular Escherichia coli, Salmonella sp. and Clostridium perfringens.
EXPIRY DATE:
24 months from date of manufacture.
SPECIAL STORAGE MEASURES:
In a dry and dark place, inaccessible to children, at a temperature between 5 and 25°C.
The symbiosis of these bacteria improves the intestinal microflora, reduces the risk of bacterial diseases due to the natural displacement of opportunistic bacteria, stimulating the growth of lactic acid bacteria. The high enzymatic activity of these bacteria supports digestive processes, improves feed digestion and nutrient absorption. Due to the stimulation of phagocytic activity of monocytes and neutrophils, the increase in functional activity of macrophages, the induction of endogenous interferon and the increase in the content of the gamma-globulin fraction in the blood, non-specific immunity is increased.